Product news

Share this article:

Vivius has received FDA approval for the marketing of Evamist, a metered dose transdermal estradiol spray for the treatment of moderate to severe vasomotor symptoms due to menopause. Evamist is the first estradiol transdermal spray approved by the FDA.

Wyeth announced that Lybrel (90 mcg levonorgestrel/20 mcg ethinyl estradiol tablets) is now available by prescription in US pharmacies. Lybrel is indicated for the prevention of pregnancy and is the first and only low dose combination contraceptive pill taken 365 days a year, without a placebo phase or pill-free interval.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.